Form 13G Quoin Pharmaceuticals For: 2 February
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Quoin Pharmaceuticals Ltd DRC (QNRX)
Quoin Pharmaceuticals Ltd DRC stock price live, this page displays NASDAQ QNRX stock exchange data. View the QNRX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Quoin Pharmaceuticals Ltd DRC real time stock price chart below.
What Is the Quoin Pharmaceuticals Ltd DRC Stock Price Today?
The Quoin Pharmaceuticals Ltd DRC stock price today is 7.1400.
What Is the Stock Symbol for Quoin Pharmaceuticals Ltd DRC?
The stock symbol for Quoin Pharmaceuticals Ltd DRC is "QNRX."
What Stock Exchange Does Quoin Pharmaceuticals Ltd DRC Trade On?
Quoin Pharmaceuticals Ltd DRC is listed and trades on the NASDAQ stock exchange.
Is Quoin Pharmaceuticals Ltd DRC a Good Stock to Buy?
Determining whether Quoin Pharmaceuticals Ltd DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the QNRX quote. (ISIN: US74907L4095)
What Is the Quoin Pharmaceuticals Ltd DRC Stock Price Today?
The Quoin Pharmaceuticals Ltd DRC stock price today is 7.1400.
What Is the Stock Symbol for Quoin Pharmaceuticals Ltd DRC?
The stock symbol for Quoin Pharmaceuticals Ltd DRC is "QNRX."
What Stock Exchange Does Quoin Pharmaceuticals Ltd DRC Trade On?
Quoin Pharmaceuticals Ltd DRC is listed and trades on the NASDAQ stock exchange.
Is Quoin Pharmaceuticals Ltd DRC a Good Stock to Buy?
Determining whether Quoin Pharmaceuticals Ltd DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the QNRX quote. (ISIN: US74907L4095)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.1400
8.0050
52 wk Range
5.0100
41.8000
QNRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.14008.0050
52 wk Range
5.010041.8000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
QNRX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
40.6667
Upside
+469.56%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
- Form 13G Quoin Pharmaceuticals For: 11 December
- Investing.com
- Form 13G Quoin Pharmaceuticals For: 28 January
- Investing.com
- Form 13G Quoin Pharmaceuticals For: 2 February
- Investing.com
- Form 13G Quoin Pharmaceuticals For: 28 January
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Quoin Pharmaceuticals Ltd DRC Company Profile
Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company’s lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Compare QNRX to Peers and Sector
Metrics to compare | QNRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipQNRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | −2.1x | −0.5x | |
PEG Ratio | −0.01 | −0.02 | 0.00 | |
Price/Book | −4.9x | 2.2x | 2.6x | |
Price / LTM Sales | - | 39.1x | 3.3x | |
Upside (Analyst Target) | 278.2% | 408.5% | 45.8% | |
Fair Value Upside | Unlock | 12.5% | 6.4% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 40.6667
(+469.56% Upside)
Earnings
Latest Release
Nov 06, 2025
EPS / Forecast
-6.72 / -0.60
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Quoin Pharmaceuticals DRC (QNRX) Stock Price Today?
The Quoin Pharmaceuticals DRC stock price today is 7.1400
What Stock Exchange Does Quoin Pharmaceuticals DRC Trade On?
Quoin Pharmaceuticals DRC is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Quoin Pharmaceuticals DRC?
The stock symbol for Quoin Pharmaceuticals DRC is "QNRX."
What Is the Quoin Pharmaceuticals DRC Market Cap?
As of today, Quoin Pharmaceuticals DRC market cap is 5.99M.
What Is Quoin Pharmaceuticals DRC's Earnings Per Share (TTM)?
The Quoin Pharmaceuticals DRC EPS (TTM) is -28.39.
From a Technical Analysis Perspective, Is QNRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Quoin Pharmaceuticals DRC Stock Split?
Quoin Pharmaceuticals DRC has split 3 times.
How Many Employees Does Quoin Pharmaceuticals DRC Have?
Quoin Pharmaceuticals DRC has 4 employees.
What is the current trading status of Quoin Pharmaceuticals DRC (QNRX)?
As of Feb 08, 2026, Quoin Pharmaceuticals DRC (QNRX) is trading at a price of 7.1400, with a previous close of 7.8200. The stock has fluctuated within a day range of 7.1400 to 8.0050, while its 52-week range spans from 5.0100 to 41.8000.
What Is Quoin Pharmaceuticals DRC (QNRX) Price Target According to Analysts?
The average 12-month price target for Quoin Pharmaceuticals DRC is USD40.6667, with a high estimate of USD70 and a low estimate of USD25. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +469.56% Upside potential.
What Is the QNRX After Hours Price?
QNRX's last after hours stock price is 7.3000, the stock has decreased by 0.1600, or 2.2400%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.